Petros Pharmaceuticals, Inc.
PTPI
$0.0305
-$0.0011-3.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.42M | -14.32M | -4.73M | -7.06M | -8.94M |
| Total Depreciation and Amortization | 2.19M | 2.19M | 2.36M | 2.45M | 2.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.49M | 6.74M | -5.76M | -4.19M | -2.71M |
| Change in Net Operating Assets | 2.61M | 2.79M | 2.30M | -311.70K | 1.08M |
| Cash from Operations | -3.13M | -2.60M | -5.83M | -9.10M | -8.01M |
| Capital Expenditure | -24.50K | -24.50K | -19.10K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.50K | -24.50K | -19.10K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -765.30K | -765.30K | -1.14M | -1.12M | -1.11M |
| Issuance of Common Stock | 8.71M | -- | 0.00 | 15.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -5.11M | -6.23M | -7.09M | -4.70M | -3.12M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.83M | -7.00M | -8.23M | 9.18M | 10.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -323.80K | -9.63M | -14.08M | 75.20K | 2.76M |